(Total Views: 140)
Posted On: 06/20/2019 1:05:45 PM
Post# of 15415
$VTGN News Article - VistaGen Announces Positive Preclinical Data Supporting AV-101's Potential For Treating Levodopa-Induced Dyskinesia In Patients With Parkinson's Disease, Without The Psychological Side Effects And Safety Concerns Of Amantadine https://marketwirenews.com/news-releases/vist...89192.html
(0)
(0)
My Twitter: WhyteStocks
